Shuping C. Que

225 Changhai Road
Shanghai, 200438, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Large pore-sized organosilica nanoparticles with controlled release of glucose oxidase for tumor-specific cascaded catalytic therapy.

Large pore-sized organosilica nanoparticles with controlled release of glucose oxidase for tumor-specific cascaded catalytic therapy.

Journal: Biomaterials science

Published: December 02, 2025

Liver fibrosis and cirrhosis in the multi-omics era: mechanisms and therapeutic perspectives from human and animal models.

Liver fibrosis and cirrhosis in the multi-omics era: mechanisms and therapeutic perspectives from human and animal models.

Journal: Frontiers in cellular and infection microbiology

Published: November 21, 2025

A review of omics studies in sarcopenia: from molecular mechanisms to hepatic-gut-muscle interactions in chronic liver disease comorbidity.

A review of omics studies in sarcopenia: from molecular mechanisms to hepatic-gut-muscle interactions in chronic liver disease comorbidity.

Journal: Frontiers in cellular and infection microbiology

Published: September 22, 2025

Correction: Current understanding on inferior quality of liver grafts by donation after circulatory death based on multi-omics data.

Correction: Current understanding on inferior quality of liver grafts by donation after circulatory death based on multi-omics data.

Journal: Frontiers in immunology

Published: May 23, 2025

Role of Iron Metabolic Disturbances and Inflammatory Iron Biomarkers in Liver Transplant Prognosis.

Role of Iron Metabolic Disturbances and Inflammatory Iron Biomarkers in Liver Transplant Prognosis.

Journal: International journal of medical sciences

Published: March 10, 2025

Molecular residual disease assessment based on tumor-informed assay predict disease progression and postoperative recurrence of hepatobiliary cancer: A preliminary study.

Molecular residual disease assessment based on tumor-informed assay predict disease progression and postoperative recurrence of hepatobiliary cancer: A preliminary study.

Journal: The International journal of biological markers

Published: March 04, 2025

Molecular Mechanisms of Ischemia/Reperfusion Injury and Graft Dysfunction in Liver Transplantation: Insights from Multi-Omics Studies in Rodent Animal Models.

Molecular Mechanisms of Ischemia/Reperfusion Injury and Graft Dysfunction in Liver Transplantation: Insights from Multi-Omics Studies in Rodent Animal Models.

Journal: International journal of biological sciences

Published: December 26, 2024

Current understanding on inferior quality of liver grafts by donation after circulatory death based on multi-omics data.

Current understanding on inferior quality of liver grafts by donation after circulatory death based on multi-omics data.

Journal: Frontiers in immunology

Published: December 20, 2024

Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatinib plus PD-1 Inhibitors.

Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatinib plus PD-1 Inhibitors.

Journal: Oncology research and treatment

Published: November 07, 2024

ACTB may serve as a predictive marker for the efficacy of lenvatinib in patients with HBV-related early-stage hepatocellular carcinoma following partial hepatectomy: a retrospective cohort study.

ACTB may serve as a predictive marker for the efficacy of lenvatinib in patients with HBV-related early-stage hepatocellular carcinoma following partial hepatectomy: a retrospective cohort study.

Journal: Journal of gastrointestinal oncology

Published: November 29, 2023

Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcinoma Patients Treated With Lenvatinib, PD-1 Inhibitors, in Combination With TACE.

Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcinoma Patients Treated With Lenvatinib, PD-1 Inhibitors, in Combination With TACE.

Journal: Technology in cancer research & treatment

Published: October 18, 2023

Multi-omics analysis reveals a crosstalk between ferroptosis and peroxisomes on steatotic graft failure after liver transplantation.

Multi-omics analysis reveals a crosstalk between ferroptosis and peroxisomes on steatotic graft failure after liver transplantation.

Journal: MedComm

Published: July 21, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026